These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 11367354

  • 1. A new acronym, a new threat: IRU.
    Proj Inf Perspect; 1999 Sep; (28):11. PubMed ID: 11367354
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
    Lin YC, Yang CH, Lin CP, Yang CM, Chen MS, Chen MY, Sheng WH, Hung CC, Chang SC.
    Ocul Immunol Inflamm; 2008 Sep; 16(3):83-7. PubMed ID: 18569793
    [Abstract] [Full Text] [Related]

  • 5. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ, Charonis AC, Holland GN, Narayanan R, Kulkarni AD, Yu F, Boyer DS, Engstrom RE, Kuppermann BD, Southern California HIV/Eye Consortium.
    Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR, Jabs DA.
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [Abstract] [Full Text] [Related]

  • 7. Ganciclovir implants: one year later.
    Cadman J.
    GMHC Treat Issues; 1997 Dec; 11(4/5):3-6. PubMed ID: 11364375
    [Abstract] [Full Text] [Related]

  • 8. The eyes have it, too.
    Neger RE.
    Posit Aware; 1996 Dec; 7(3):10-1. PubMed ID: 11363423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [Abstract] [Full Text] [Related]

  • 12. CMV trial enrolling.
    Vazquez E.
    Posit Aware; 1997 Aug; 8(4):13. PubMed ID: 11364480
    [Abstract] [Full Text] [Related]

  • 13. CMV after HAART.
    Posit Aware; 1998 Aug; 9(5):18, 23. PubMed ID: 11365888
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First eye implant approved.
    AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral ganciclovir: role in maintenance therapy for CMV retinitis in AIDS patients.
    Owens RC, Ross JW.
    Conn Med; 1996 Nov; 60(11):663-5. PubMed ID: 8979433
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ganciclovir implant in the treatment of cytomegalovirus retinitis.
    Chang M, Dunn JP.
    Expert Rev Med Devices; 2005 Jul; 2(4):421-7. PubMed ID: 16293081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.